98835-90-6

Basic information

• Product Name: Octyl 5-N,N-diethylamino-2-phenylsulfonyl-2,4-pentadienoate
• Synonyms: 5-(Diethylamino)-2-(phenylsulfonyl)-2,4-pentadienoic acid octyl ester;Octyl 5-N,N-diethylamino-2-phenylsulfonyl-2,4-pentadienoate;(2Z,4E)-octyl 5-(diethylamino)-2-(phenylsulfonyl)penta-2,4-dienoate
• CAS NO: 98835-90-6
• Molecular Formula: C₂₃H₃₅NO₄S
• Molecular Weight: 421.59
• Mol File: 98835-90-6.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Density: 1.072
• CAS DataBase Reference: Octyl 5-N,N-diethylamino-2-phenylsulfonyl-2,4-pentadienoate(CAS DataBase Reference)
• NIST Chemistry Reference: Octyl 5-N,N-diethylamino-2-phenylsulfonyl-2,4-pentadienoate(98835-90-6)
• EPA Substance Registry System: Octyl 5-N,N-diethylamino-2-phenylsulfonyl-2,4-pentadienoate(98835-90-6)

Safety Data

• Hazardous Substances Data: 98835-90-6(Hazardous Substances Data)

Usage

Description

Octyl 5-N,N-diethylamino-2-phenylsulfonyl-2,4-pentadienoate is a carboxylic acid organic compound characterized by its unique molecular structure that features an octyl chain, a diethylamino group, and a phenylsulfonyl moiety attached to a 2,4-pentadienoate backbone. This complex arrangement endows the compound with specific chemical properties that make it suitable for various applications, particularly in the pharmaceutical industry.

Uses

Used in Pharmaceutical Industry:
Octyl 5-N,N-diethylamino-2-phenylsulfonyl-2,4-pentadienoate is used as a pharmaceutical intermediate for the synthesis of various drug compounds. Its unique structure allows it to serve as a building block in the development of new medications, potentially contributing to the creation of innovative treatments for a range of medical conditions.
As a pharmaceutical intermediate, Octyl 5-N,N-diethylamino-2-phenylsulfonyl-2,4-pentadienoate plays a crucial role in the chemical synthesis processes that produce active pharmaceutical ingredients (APIs). Its presence in the molecular structure of these APIs can influence their pharmacological properties, such as solubility, stability, and bioavailability, which are essential factors in determining the efficacy and safety of the final drug product.

Relevant articles and documents

COSMETIC COMPOSITIONS COMPRISING AN ESTER DERIVED FROM 4-CARBOXY-2-PYRROLIDINONE AND A LIPOPHILIC SCREENING AGENT; USE OF SAID DERIVATIVE AS A SOLVENT FOR A BENZOPHENONE LIPOPHILIC SCREENING AGENT

The present invention relates to a composition comprising, in a cosmetically acceptable medium, at least one ester derived from 4-carboxy-2-pyrrolidinone, of formula (I) below: in which: R1 denotes a linear or branched C1-C20 alkyl radical,R2 denotes a linear or branched C1-C20 alkyl radical that may contain a C5-C6 ring, the phenyl radical, the benzyl radical or the phenethyl radical,and at least one benzophenone-type lipophilic UV screening agent. The present invention also relates to the use of at least one ester derived from 4-carboxy-2-pyrrolidinone, of formula (I), as defined above, in a composition comprising, in a cosmetically acceptable medium, at least one benzophenone-type lipophilic UV screening agent, as a solvent for said benzophenone screening agent, in and/or as an agent for improving the solubility of said benzophenone screening agent in said composition or with the aim of improving the sun protection factor.

COSMETIC AND/OR DERMATOLOGICAL COMPOSITION BASED ON N,N'-DIARYLMETHYLENEETHYLENEDIAMINEDIACETIC ACID ESTER(S)

The present invention relates to a cosmetic and/or dermatological composition comprising, in a physiologically acceptable medium containing at least one oil: (a) at least one compound of general formula (Ia): and (b) an efficient amount of at least one solvent chosen from: (i) isononyl isononanoate;(ii) dimethyl isosorbide;(iii) the amino acid esters of formula (II): [in-line-formulae]R′1(CO)N(R′2)CH(R′3)(CH2)n(CO)OR′4??(II)[/in-line-formulae](iv) and a mixture thereof.

COMPOSITION CONTAINING A SUPERABSORBENT POLYMER AND AN ORGANIC UV SCREENING AGENT

A composition in the form of an emulsion containing an aqueous phase, a fatty phase, a superabsorbent polymer, and an organic UV screening agent. Method for the treatment of a keratinous substance whereby the composition described is applied to the keratinous substance.